DOCS (Doximity, Inc.) Stock Analysis - Analyst Ratings

Doximity, Inc. (DOCS) is a publicly traded Healthcare sector company. As of May 20, 2026, DOCS trades at $19.65 with a market cap of $3.62B and a P/E ratio of 15.59. DOCS moved +3.30% today. Year to date, DOCS is -56.53%; over the trailing twelve months it is -62.53%. Its 52-week range spans $17.15 to $85.21. Analyst consensus is buy with an average price target of $26.78. Rallies surfaces DOCS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate DOCS?

21 analysts cover DOCS: 0 strong buy, 9 buy, 12 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $26.78.

DOCS Key Metrics

Key financial metrics for DOCS
MetricValue
Price$19.65
Market Cap$3.62B
P/E Ratio15.59
EPS$1.27
Dividend Yield0.00%
52-Week High$85.21
52-Week Low$17.15
Volume3.63M
Avg Volume0
Revenue (TTM)$637.78M
Net Income$239.40M
Gross Margin89.75%

DOCS Analyst Consensus

21 analysts cover DOCS: 0 strong buy, 9 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.78.

Latest DOCS News

Recent DOCS Insider Trades

  • Sitaram Siddharth sold 2.31K (~$59.50K) on May 11, 2026.
  • Wampler Kira Scherer sold 9.00K (~$234.54K) on May 7, 2026.
  • Sitaram Siddharth sold 2.43K (~$51.19K) on Apr 10, 2026.

Common questions about DOCS

What do analysts rate DOCS?
21 analysts cover DOCS: 0 strong buy, 9 buy, 12 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $26.78.
Does Rallies show DOCS price targets?
Yes. Rallies tracks DOCS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is DOCS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DOCS. It does not provide personalized investment advice.
DOCS

DOCS